AU2004907196A0 - Use of Naltrexone for Treating Alzheimer's Disease - Google Patents

Use of Naltrexone for Treating Alzheimer's Disease

Info

Publication number
AU2004907196A0
AU2004907196A0 AU2004907196A AU2004907196A AU2004907196A0 AU 2004907196 A0 AU2004907196 A0 AU 2004907196A0 AU 2004907196 A AU2004907196 A AU 2004907196A AU 2004907196 A AU2004907196 A AU 2004907196A AU 2004907196 A0 AU2004907196 A0 AU 2004907196A0
Authority
AU
Australia
Prior art keywords
naltrexone
disease
treating alzheimer
alzheimer
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004907196A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edith Cowan University
Original Assignee
Edith Cowan University
Filing date
Publication date
Application filed by Edith Cowan University filed Critical Edith Cowan University
Publication of AU2004907196A0 publication Critical patent/AU2004907196A0/en
Abandoned legal-status Critical Current

Links

AU2004907196A 2004-12-20 Use of Naltrexone for Treating Alzheimer's Disease Abandoned AU2004907196A0 (en)

Publications (1)

Publication Number Publication Date
AU2004907196A0 true AU2004907196A0 (en) 2005-01-06

Family

ID=

Similar Documents

Publication Publication Date Title
HUS1500043I1 (en) Methods for treatment of parkinson's disease
EP1940373B8 (en) 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease
EP1809601A4 (en) Compounds for alzheimer's disease
EP1765388B8 (en) Combination therapy for preventing or treating alzheimer's disease, and kit therefor
EP1583750A4 (en) Macrocyclic beta-secretase inhibitors for treatment of alzheimer's disease
HK1091815A1 (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
EP1758854A4 (en) Pyrrolidin-3-yl compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
EP1656359A4 (en) Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
EP1745060A4 (en) Compounds for treating alzheimer's disease and for inhibiting beta-amyloid peptide production
AU2003206413A1 (en) Substituted amino carboxamides for the treatment of alzheimer's disease
AU2005313582A8 (en) Malonamide derivatives as inhibitors of gamma-secretase for the treatment of Alzheimer's disease
EP1814537A4 (en) Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease
AU2003217275A1 (en) Azabicyclic compounds for the treatment of disease
IL180513A0 (en) Process for synthesis of 4-4'-diamino-diphenyl-sulfone
GB0329874D0 (en) Compounds useful for the treatment of diseases
AU2003254146A1 (en) Methods for the treatment of parkinson's disease
IL184849A0 (en) Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
AU2003238046A1 (en) Substituted 3- and 4- aminomethylpiperidines for use as beta-secretase in the treatment of alzheimer's disease
AU2003273310A1 (en) Substituted aminoethers for the treatment of alzheimer's disease
AU2003284898A1 (en) Combinative nicotinic/d1 agonism therapy for the treatment of alzheimer's disease
GB0414894D0 (en) Biomarkers of alzheimer's disease
GB0400802D0 (en) Compounds for the treatment of disease
EP1832877A4 (en) Method of examining alzheimer's disease
AU2003299101A1 (en) Compounds for the treatment of alzheimer's disease
AU2004907196A0 (en) Use of Naltrexone for Treating Alzheimer's Disease